Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Baumann

Showing results (41-50 of 412) with videos related to

Pageof 42
Sort By:
Molecular Oncology|March 3, 2012
Individualization of cancer treatment from radiotherapy perspectiveAla Yaromina, Mechthild Krause, Michael Baumann
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2016
Clinical trials for personalized glioblastoma radiotherapy: Markers for efficacy and late toxicity but often delayed treatment - Does that matter?Annika Lattermann, Michael Baumann, Mechthild Krause
Rays|November 22, 2005
TCP and NTCP in preclinical and clinical research in EuropeMichael Baumann, Cordula Petersen, Mechthild Krause
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 8, 2014
Application of organ tolerance dose-constraints in clinical studies in radiation oncologyWolfgang Dörr, Thomas Herrmann, Michael Baumann
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 26, 2009
Radiotherapy of lung cancer: technology meets biology meets multidisciplinarityMichael Baumann, Daniel Zips, Steffen Appold
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 6, 2004
In vivo verification of electron beam energy by patient exit dose and optical density of portal filmsPeter Geyer, Wolfgang W Baus, Michael Baumann
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
Towards genetic prediction of radiation responses: ESTRO's GENEPI projectMichael Baumann, Tobias Hölscher, Adrian C Begg
In Vivo (Athens, Greece)|March 31, 2005
New anticancer agents: in vitro and in vivo evaluationDaniel Zips, Howard D Thames, Michael Baumann
Molecular Cancer Research : MCR|August 19, 2007
Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activityMahmoud Toulany, Michael Baumann, H Peter Rodemann
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
In regard to Solomon et al.: EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. IJROBP 2003;55:713-723Mechthild Krause, Michael Baumann, Howard D Thames
Pageof 42

Showing results (41-50 of 412) with videos related to

Sort By:
Pageof 42
Molecular Oncology|March 3, 2012
Individualization of cancer treatment from radiotherapy perspectiveAla Yaromina, Mechthild Krause, Michael Baumann
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2016
Clinical trials for personalized glioblastoma radiotherapy: Markers for efficacy and late toxicity but often delayed treatment - Does that matter?Annika Lattermann, Michael Baumann, Mechthild Krause
Rays|November 22, 2005
TCP and NTCP in preclinical and clinical research in EuropeMichael Baumann, Cordula Petersen, Mechthild Krause
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 8, 2014
Application of organ tolerance dose-constraints in clinical studies in radiation oncologyWolfgang Dörr, Thomas Herrmann, Michael Baumann
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 26, 2009
Radiotherapy of lung cancer: technology meets biology meets multidisciplinarityMichael Baumann, Daniel Zips, Steffen Appold
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 6, 2004
In vivo verification of electron beam energy by patient exit dose and optical density of portal filmsPeter Geyer, Wolfgang W Baus, Michael Baumann
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
Towards genetic prediction of radiation responses: ESTRO's GENEPI projectMichael Baumann, Tobias Hölscher, Adrian C Begg
In Vivo (Athens, Greece)|March 31, 2005
New anticancer agents: in vitro and in vivo evaluationDaniel Zips, Howard D Thames, Michael Baumann
Molecular Cancer Research : MCR|August 19, 2007
Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activityMahmoud Toulany, Michael Baumann, H Peter Rodemann
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
In regard to Solomon et al.: EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. IJROBP 2003;55:713-723Mechthild Krause, Michael Baumann, Howard D Thames
Pageof 42